Viewing Study NCT00000833


Ignite Creation Date: 2025-12-25 @ 3:03 AM
Ignite Modification Date: 2025-12-26 @ 8:24 AM
Study NCT ID: NCT00000833
Status: COMPLETED
Last Update Posted: 2021-10-28
First Post: 1999-11-02
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase I Study of Combination Therapy With Didanosine (ddI) and Ribavirin in HIV-Infected Children.
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: None
Start Date Type: None
Primary Completion Date: None
Primary Completion Date Type: None
Completion Date: 1998-07
Completion Date Type: ACTUAL
First Submit Date: 1999-11-02
First Submit QC Date: None
Study First Post Date: 2001-08-31
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2021-10-27
Last Update Post Date: 2021-10-28
Last Update Post Date Type: ACTUAL